FocusFibrosis

Relief from Within: A Peptide Therapy for Fibrosis

Science Translational Medicine  30 May 2012:
Vol. 4, Issue 136, pp. 136fs16
DOI: 10.1126/scitranslmed.3004138

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

A modified, natural peptide derived from the antiangiogenic molecule endostatin has the potential to become a breakthrough therapy for organ fibrosis (Yamaguchi et al., this issue).

View Full Text